SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882104-19-000111
Filing Date
2019-11-06
Accepted
2019-11-06 16:14:13
Documents
102
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pdli-2019093010qdoc.htm 10-Q 2422198
2 CERTIFICATION pdli-2019093010qex311.htm EX-31.1 10975
3 CERTIFICATION pdli-2019093010qex321.htm EX-32.1 10644
10 pdllogoa28.jpg GRAPHIC 123123
  Complete submission text file 0000882104-19-000111.txt   13322665

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT pdli-20190930.xml EX-101.INS 2809384
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20190930.xsd EX-101.SCH 116730
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20190930_cal.xml EX-101.CAL 131116
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20190930_def.xml EX-101.DEF 747254
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20190930_lab.xml EX-101.LAB 1167855
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20190930_pre.xml EX-101.PRE 916799
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 191196447
SIC: 2836 Biological Products, (No Diagnostic Substances)